March 26, 2018 Coding Q&A
AAPM&R and ACRM Form a Strategic Alliance to Increase Awareness of the Value of Rehabilitation as Medicine
Advocacy Action Center: Urge Your Senator to Protect the Americans with Disabilities Act (ADA) of 1990
What's New Related to Drugs
NEW Course - Navigating the Opioid Crisis: Perils, Pitfalls, and Practical Solutions Course
Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Methylprednisolone Sodium Succinate for Injection, USP, 40mg, 125mg, and 1g Due to High Out of Specification Impurity Results
PM&R Expertise in Stroke Care Exhibited in JAMA
Clarity of Purpose: FDA-Approved mTBI Blood Test
Advocacy Action Center: BCBS of Michigan: Hyaluronan Injections No Longer Payable (Effective 4/1/18)
Hydromorphone HCL Injection USP by Hospira: Recall - Potential For Empty Or Cracked Glass Vials
The 2018 Winter Paralympic Games Starts Friday!
Look for Your March Issue of The Physiatrist
Compounded Drug Products from Cantrell Drug Company: FDA Warning - Serious Deficiencies in Quality and Sterility Assurance
Now Available: Update in Opioid Management SAE-P
Apply Now: Call for PhyzTalks
March Coding Q&A
CMS Seeks Provider Input on Evaluation and Management Services
AAPM&R Members in the News: February 2018
AAPM&R Advocacy Efforts Result in Reversal of Anthem Modifier 25 Reduction Policy
AAPM&R Receives Grant to Improve Intellectual/Developmental Disabilities (IDD) Education